Efficacy Observational Study of Candesartan Cilexetil on Hypertensive Patients

Candesartan Effect in Second Stage Arterial Hypertension

NCT00621153 ·Status: COMPLETED ·Phase: PHASE4

A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension

NCT02059616 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy

NCT02368652 ·Status: COMPLETED ·Phase: PHASE3

Bioavailability Study of Candesartan Cilexetil 8mg Tablet Under Fasting Conditions

NCT02006589 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide

NCT00360178 ·Status: COMPLETED ·Phase: PHASE3

Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France

NCT00679640 ·Status: COMPLETED

Candesartan Cilexetil/Amlodipine Besilate Combination Tablets LD, HD Special Drug Use Surveillance "Hypertension: Long-Term Use"

NCT02068495 ·Status: COMPLETED

Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.

NCT00775814 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy

NCT02368665 ·Status: COMPLETED ·Phase: PHASE3

Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ Amlodipine

NCT01613209 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age

NCT00244595 ·Status: COMPLETED ·Phase: PHASE3

COmpliance and Efficacy in Mono and Combination Tablet Study ATacand/Atacand Plus

NCT00526279 ·Status: COMPLETED

Evaluation of Atacand® (Candesartan) in Daily Medical Practice

NCT00837720 ·Status: COMPLETED

Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension

NCT01289132 ·Status: COMPLETED ·Phase: PHASE2

Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)

NCT00348686 ·Status: COMPLETED ·Phase: PHASE4

Atacand Dose Ranging in Hypertensive Pediatric Subjects 1 Year to Less Than 6 Years of Age

NCT00244621 ·Status: COMPLETED ·Phase: PHASE3

Candesartan Cilexetil / Hydrochlorothiazide Combination Tablets Special Drug Use Surveillance: Long-term Use (12 Months)

NCT02016183 ·Status: COMPLETED

High Doses of Candesartan Cilexetil on the Reduction of Proteinuria

NCT00242346 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mg

NCT01611077 ·Status: COMPLETED ·Phase: PHASE4

Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome

NCT00394745 ·Status: COMPLETED ·Phase: PHASE3

Efficacy/Safety of Cilnidipine Plus Valsartan Versus Valsartan in Patients With Hypertension

NCT02145104 ·Status: COMPLETED ·Phase: PHASE3

A Relative Bioavailability Study of a Fixed Dose Combination (FDC) Tablets of GSK587323

NCT02094924 ·Status: COMPLETED ·Phase: PHASE1

Candesartan Cilexetil Special Drug Use Surveillance 「Challenge - Quality Control」

NCT02211638 ·Status: COMPLETED

Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension

NCT00523744 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Aliskiren + Hydrochlorothiazide (± Amlodipine 5 mg) in Patients With Moderate Hypertension

NCT00867490 ·Status: COMPLETED ·Phase: PHASE3